Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Apollomics (APLM)
NASDAQ:APLM
Apollomics (APLM) Stock Price & Analysis
237 Followers
APLM Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.18 - $5.80
Previous Close$0.21
Volume467.62K
Average Volume (3M)1.04M
Market Cap
$21.71M
Enterprise Value-$3.74M
Total Cash (Recent Filing)$32.06M
Total Debt (Recent Filing)$5.66M
Price to Earnings (P/E)―
Beta1.29
Next Earnings
Sep 26, 2024EPS Estimate
-$0.18Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.80
Shares Outstanding89,495,790
10 Day Avg. Volume539,602
30 Day Avg. Volume1,038,965
Standard Deviation0.35
R-Squared0.04
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)0.69
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda9.74
Forecast
1Y Price Target
$2.00Price Target Upside901.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Apollomics News
Bulls Say, Bears Say
Bulls Say
Clinical AdvancementsApollomics continues to advance its lead asset, vebreltinib, in the SPARTA clinical program encompassing c-Met-dysregulated cancers.
Financial StrengthApollomics trades at a modestly negative enterprise value and possesses an extensive early-stage pipeline.
Trial ResultsUproleselan shows higher remission rate and improved overall survival in trials, with pivotal trial results looking encouraging.
Bears Say
Clinical TrialsUproleselan misses primary endpoint in Phase 3 trial for r/r AML—reducing price target.
Financial PerformanceApollomics reported a net loss of $3.37 per share.
Future ProjectionsAnalyst projects a full-year 2024 net loss of $0.66 per share, an increase from the prior estimate.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
0.06% Mutual Funds
8.72% Other Institutional Investors
91.23% Public Companies and
Individual Investors
APLM FAQ
What was Apollomics’s price range in the past 12 months?
Apollomics lowest stock price was $0.18 and its highest was $5.80 in the past 12 months.
What is Apollomics’s market cap?
Currently, no data Available
When is Apollomics’s upcoming earnings report date?
Apollomics’s upcoming earnings report date is Sep 26, 2024 which is in 66 days.
How were Apollomics’s earnings last quarter?
Apollomics released its earnings results on Mar 28, 2024. The company reported -$0.24 earnings per share for the quarter, missing the consensus estimate of -$0.15 by -$0.09.
Is Apollomics overvalued?
According to Wall Street analysts Apollomics’s price is currently Undervalued.
Does Apollomics pay dividends?
Apollomics does not currently pay dividends.
What is Apollomics’s EPS estimate?
Apollomics’s EPS estimate is -$0.18.
How many shares outstanding does Apollomics have?
Apollomics has 108,662,450 shares outstanding.
What happened to Apollomics’s price movement after its last earnings report?
Apollomics reported an EPS of -$0.24 in its last earnings report, missing expectations of -$0.15. Following the earnings report the stock price went up 25%.
Which hedge fund is a major shareholder of Apollomics?
Among the largest hedge funds holding Apollomics’s share is Saba Capital Management. It holds Apollomics’s shares valued at N/A.
---
Apollomics Stock Smart Score
Company Description
Apollomics
Maxpro Capital Acquisition Corp is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
---
APLM Stock 12 Month Forecast
Average Price Target
$2.00
▲(901.00% Upside)
Technical Analysis
Best Analysts Covering APLM
1 Year
1 Year Success Rate
0/5 ratings generated profit
1 Year Average Return
-76.50%
reiterated a buy rating 3 months ago
Copying Robert Burns's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -76.50% per trade.
---